首页 > 最新文献

Revista de Patologia Respiratoria最新文献

英文 中文
Resolución de múltiples nódulos pulmonares cavitados con el abandono del hábito tabáquico como único tratamiento 以戒烟为唯一治疗方法,解决多个空化肺结节
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/S1576-9895(12)70159-5
M.L. Estévez , C. Pinedo , M. Rodríguez Masi , I. Guerassimova , P. Benedetti , B. Cabeza , G. Rodríguez Trigo

The term histiocytosis refers to a heterogeneous group of diseases characterized by the infiltration of Langerhans cells (LC) in different organs. Pulmonary Histiocytosis (PH) is an uncommon disease that typically affects young adults. Its pathogeny is not well known, although a relationship with smoking has been observed. Thus, the first treatment measure should be smoking cessation. We present a case of pulmonary histiocytosis that showed a favorable clinical, functional and radiological course in six months as a consequence of using smoking cessation as the only treatment.

组织细胞增多症是指以朗格汉斯细胞(LC)浸润于不同器官为特征的异质性疾病。肺组织细胞增多症(PH)是一种罕见的疾病,通常影响年轻人。其发病机制尚不清楚,但已观察到与吸烟有关。因此,第一个治疗措施应该是戒烟。我们报告一个肺组织细胞增多症的病例,在使用戒烟作为唯一治疗的结果,在六个月内显示出良好的临床,功能和放射学过程。
{"title":"Resolución de múltiples nódulos pulmonares cavitados con el abandono del hábito tabáquico como único tratamiento","authors":"M.L. Estévez ,&nbsp;C. Pinedo ,&nbsp;M. Rodríguez Masi ,&nbsp;I. Guerassimova ,&nbsp;P. Benedetti ,&nbsp;B. Cabeza ,&nbsp;G. Rodríguez Trigo","doi":"10.1016/S1576-9895(12)70159-5","DOIUrl":"10.1016/S1576-9895(12)70159-5","url":null,"abstract":"<div><p>The term histiocytosis refers to a heterogeneous group of diseases characterized by the infiltration of Langerhans cells (LC) in different organs. Pulmonary Histiocytosis (PH) is an uncommon disease that typically affects young adults. Its pathogeny is not well known, although a relationship with smoking has been observed. Thus, the first treatment measure should be smoking cessation. We present a case of pulmonary histiocytosis that showed a favorable clinical, functional and radiological course in six months as a consequence of using smoking cessation as the only treatment.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 140-144"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70159-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56526497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importancia para una revista científica de encontrarse incluida en las grandes bases de datos internacionales 科学期刊被纳入大型国际数据库的重要性
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/S1576-9895(12)70153-4
A. Alonso Arroyo , R. Aleixandre Benavent
{"title":"Importancia para una revista científica de encontrarse incluida en las grandes bases de datos internacionales","authors":"A. Alonso Arroyo ,&nbsp;R. Aleixandre Benavent","doi":"10.1016/S1576-9895(12)70153-4","DOIUrl":"10.1016/S1576-9895(12)70153-4","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 101-103"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70153-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
El uso de los biomarcadores de inflamación en la vía aérea en el manejo del asma 气道炎症生物标志物在哮喘管理中的应用
Q4 Medicine Pub Date : 2012-10-01 DOI: 10.1016/S1576-9895(12)70157-1
S. Sánchez-Cuéllar, J. Ancochea Bermúdez

Biological markers are being used in the diagnosis and treatment of disease as prevalent as cardiovascular or cancer. Biomarkers are a useful in clinical practice as a non invasive methods for the accurate diagnosis of the disease, monitor disease and create personalized treatment regimes. Asthma is a heterogeneous disease with different phenotypes. Pulmonary function test are most often used to confirm the diagnosis, but not reflect the pathological processes responsible for different phenotypes that present the disease. Inhaled corticosteroids and beta 2 agonists have been mainstay of asthma therapy for over 30 years, but the heterogeneity of the disease means not all asthmatics respond to the same treatment. Biomarkers are useful tools to identify these specific phenotypes. This review focuses on the utility of biomarkers of inflammation of the airway in the management of asthma patients obtained by noninvasive tecniques including sputum, exhaled breath or serum.

生物标志物正被用于诊断和治疗心血管或癌症等常见疾病。生物标志物作为一种非侵入性方法在临床实践中非常有用,可用于准确诊断疾病,监测疾病并创建个性化治疗方案。哮喘是一种具有不同表型的异质性疾病。肺功能检查最常用于确认诊断,但不能反映导致疾病不同表型的病理过程。30多年来,吸入皮质类固醇和β 2激动剂一直是哮喘治疗的主流,但该病的异质性意味着并非所有哮喘患者都对相同的治疗有反应。生物标志物是识别这些特定表型的有用工具。本文综述了通过无创技术(包括痰、呼出气体或血清)获得的气道炎症生物标志物在哮喘患者管理中的应用。
{"title":"El uso de los biomarcadores de inflamación en la vía aérea en el manejo del asma","authors":"S. Sánchez-Cuéllar,&nbsp;J. Ancochea Bermúdez","doi":"10.1016/S1576-9895(12)70157-1","DOIUrl":"10.1016/S1576-9895(12)70157-1","url":null,"abstract":"<div><p>Biological markers are being used in the diagnosis and treatment of disease as prevalent as cardiovascular or cancer. Biomarkers are a useful in clinical practice as a non invasive methods for the accurate diagnosis of the disease, monitor disease and create personalized treatment regimes. Asthma is a heterogeneous disease with different phenotypes. Pulmonary function test are most often used to confirm the diagnosis, but not reflect the pathological processes responsible for different phenotypes that present the disease. Inhaled corticosteroids and beta 2 agonists have been mainstay of asthma therapy for over 30 years, but the heterogeneity of the disease means not all asthmatics respond to the same treatment. Biomarkers are useful tools to identify these specific phenotypes. This review focuses on the utility of biomarkers of inflammation of the airway in the management of asthma patients obtained by noninvasive tecniques including sputum, exhaled breath or serum.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 4","pages":"Pages 129-135"},"PeriodicalIF":0.0,"publicationDate":"2012-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70157-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56526490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leiomiomatosis benigna pulmonar metastatizante 转移性肺良性平滑肌瘤病
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70149-2
D. Palafox , J. Palafox , G. Aquino , W.L. Dajer-Fadel

Pulmonary benign metastasising leiomyomatosis is an uncommon disease characterized by the presence of pulmonary leiomyomas, in the absence of malignancy criteria in a patient with previous uterin leiomyomatosis. The disease is very uncommon and should be considered amongst the differential diagnosis of pulmonary benign tumors. Due to the challenge that represents to health care providers specialized in respiratory pathology in the diagnosis and management of these type of patients, we present the case of a patient with hysterectomy for uterin myomatosis in which the diagnosis of pulmonary benign metastasising leiomyomatosis was established and treated successfully.

肺良性转移性平滑肌瘤病是一种罕见的疾病,其特征是肺平滑肌瘤的存在,在既往子宫平滑肌瘤病患者中没有恶性标准。本病并不常见,应列为肺部良性肿瘤的鉴别诊断之一。由于这类患者的诊断和管理对专门从事呼吸病理学的医疗保健提供者构成挑战,我们提出了一例因子宫肌瘤病而行子宫切除术的患者,其中肺良性转移性平滑肌瘤病的诊断被确立并成功治疗。
{"title":"Leiomiomatosis benigna pulmonar metastatizante","authors":"D. Palafox ,&nbsp;J. Palafox ,&nbsp;G. Aquino ,&nbsp;W.L. Dajer-Fadel","doi":"10.1016/S1576-9895(12)70149-2","DOIUrl":"10.1016/S1576-9895(12)70149-2","url":null,"abstract":"<div><p>Pulmonary benign metastasising leiomyomatosis is an uncommon disease characterized by the presence of pulmonary leiomyomas, in the absence of malignancy criteria in a patient with previous uterin leiomyomatosis. The disease is very uncommon and should be considered amongst the differential diagnosis of pulmonary benign tumors. Due to the challenge that represents to health care providers specialized in respiratory pathology in the diagnosis and management of these type of patients, we present the case of a patient with hysterectomy for uterin myomatosis in which the diagnosis of pulmonary benign metastasising leiomyomatosis was established and treated successfully.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 85-88"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70149-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Vacuna antineumocócica
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70146-7
J.A. Riesco Miranda, M. Torres González, D. del Puerto García
{"title":"Vacuna antineumocócica","authors":"J.A. Riesco Miranda,&nbsp;M. Torres González,&nbsp;D. del Puerto García","doi":"10.1016/S1576-9895(12)70146-7","DOIUrl":"https://doi.org/10.1016/S1576-9895(12)70146-7","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 71-73"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70146-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91622392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Derrame pleural en pacientes hospitalizados en la era de la vacuna antineumocócica heptavalente 七价肺炎球菌疫苗时代住院患者的胸腔积液
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70147-9
E. Villalobos Pinto, A. Pérez Pérez, J. Cano Fernández, P. Flores Pérez, M. Sánchez–Bayle

Introduction: Invasive pneumococcal disease is one of the diseases with higher morbidity and mortality in children. Despite expectations created, we discuss the role of the heptavalent vaccine in the incidence of complicates pneumonia. Our goal is to determine if it has increased in our hospital.

Patients and methods: We studied 9068 patients admitted with the diagnosis of pneumonia in the Hospital Niño Jesús between 1996 and 2010. A retrospective, observational study, analyzing the total or partial introduction of the vaccine.

Results: Sample segregation in 3 groups according to the non introduction and the total or partial introduction of the vaccine. We confirmed an increase in pleural effusion (p< 0.005) in vaccine groups.

Conclusions: After the introduction of heptavalent pneumococcal vaccine it has been found in our sample an increase in complicated pneumonia with pleural effusion.

简介:侵袭性肺炎球菌病是儿童发病率和死亡率较高的疾病之一。尽管产生了期望,但我们讨论了七价疫苗在并发症肺炎发生率中的作用。我们的目标是确定它在我们医院是否增加了。患者和方法:我们研究了1996年至2010年在Niño Jesús医院诊断为肺炎的9068例患者。回顾性观察性研究,分析疫苗的全部或部分引进情况。结果:按未引入、全部或部分引入疫苗分为3组。我们确认胸腔积液增加(p<0.005)。结论:在引入七价肺炎球菌疫苗后,在我们的样本中发现合并胸腔积液的肺炎增加了。
{"title":"Derrame pleural en pacientes hospitalizados en la era de la vacuna antineumocócica heptavalente","authors":"E. Villalobos Pinto,&nbsp;A. Pérez Pérez,&nbsp;J. Cano Fernández,&nbsp;P. Flores Pérez,&nbsp;M. Sánchez–Bayle","doi":"10.1016/S1576-9895(12)70147-9","DOIUrl":"10.1016/S1576-9895(12)70147-9","url":null,"abstract":"<div><p><em>Introduction</em>: Invasive pneumococcal disease is one of the diseases with higher morbidity and mortality in children. Despite expectations created, we discuss the role of the heptavalent vaccine in the incidence of complicates pneumonia. Our goal is to determine if it has increased in our hospital.</p><p><em>Patients and methods</em>: We studied 9068 patients admitted with the diagnosis of pneumonia in the Hospital Niño Jesús between 1996 and 2010. A retrospective, observational study, analyzing the total or partial introduction of the vaccine.</p><p><em>Results</em>: Sample segregation in 3 groups according to the non introduction and the total or partial introduction of the vaccine. We confirmed an increase in pleural effusion (p&lt; 0.005) in vaccine groups.</p><p><em>Conclusions</em>: After the introduction of heptavalent pneumococcal vaccine it has been found in our sample an increase in complicated pneumonia with pleural effusion.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 74-77"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70147-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hernia pulmonar intercostal espontánea secundaria a cuadro de tos 自发肋间肺疝继发于咳嗽
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70150-9
I. Martínez Serna, M.A. Mariscal de Alba, F. Hermoso Alarza, R.J. Ávila Martínez, M.C. Marrón Fernández, J.C. Meneses Pardo

Lung hernias are rare entities and are primarily related to chest trauma or previous surgery. Spontaneous lung hernias are even more uncommon. We describe three cases of spontaneous intercostal pulmonary hernia, its evaluation and treatment in all its forms, from the conservative management in small hernias without significant clinical impact, to surgical treatment, either with primary closure of the chest wall or using synthetic mesh in larger hernias or in presence of signs of possible complications.

肺疝是一种罕见的疾病,主要与胸部外伤或既往手术有关。自发性肺疝更为罕见。我们描述了三例自发性肋间肺疝的评估和各种形式的治疗,从没有显著临床影响的小疝的保守治疗,到手术治疗,无论是胸壁的初步封闭或在较大的疝中使用合成补片或存在可能的并发症的迹象。
{"title":"Hernia pulmonar intercostal espontánea secundaria a cuadro de tos","authors":"I. Martínez Serna,&nbsp;M.A. Mariscal de Alba,&nbsp;F. Hermoso Alarza,&nbsp;R.J. Ávila Martínez,&nbsp;M.C. Marrón Fernández,&nbsp;J.C. Meneses Pardo","doi":"10.1016/S1576-9895(12)70150-9","DOIUrl":"10.1016/S1576-9895(12)70150-9","url":null,"abstract":"<div><p>Lung hernias are rare entities and are primarily related to chest trauma or previous surgery. Spontaneous lung hernias are even more uncommon. We describe three cases of spontaneous intercostal pulmonary hernia, its evaluation and treatment in all its forms, from the conservative management in small hernias without significant clinical impact, to surgical treatment, either with primary closure of the chest wall or using synthetic mesh in larger hernias or in presence of signs of possible complications.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 89-91"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70150-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Selección bibliográfica: asma 书目选择:哮喘
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70151-0
C. Cisneros Serrano , E. Arias Arias , J. Fernández-Lahera
{"title":"Selección bibliográfica: asma","authors":"C. Cisneros Serrano ,&nbsp;E. Arias Arias ,&nbsp;J. Fernández-Lahera","doi":"10.1016/S1576-9895(12)70151-0","DOIUrl":"10.1016/S1576-9895(12)70151-0","url":null,"abstract":"","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 92-95"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70151-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conductas de riesgo en pacientes con síndrome de apneas-hipopneas del sueño: estudio exploratorio en situaciones complejas y dinámicas de tráfico simulado 睡眠呼吸暂停-低呼吸暂停综合征患者的危险行为:复杂和动态模拟交通情况下的探索性研究
Q4 Medicine Pub Date : 2012-07-01 DOI: 10.1016/S1576-9895(12)70148-0
L.L. Di Stasi , C. Díaz–Piedra , A. Catena , G. Buela–Casal

Objective: A large consensus exists within the scientific community with regard to the existence of a high incidence of traffic accidents in people with Sleep Apnea Hypopnea Syndrome (SAHS). However, some aspects of this relationship are still in need of clarification. It has not been possible to show the likely cause of this large rate of accidents, there are possible uncontrolled, confounding factors, and some of the evaluation instruments used have low ecological validity. The goal of the study was to analyze risk behavior during driving in patients with SAS, in a virtual reality setting with simulated traffic.

Material and methods: Evaluation of risk driving behavior was carried out using the Honda Riding Trainer simulator. The participants were 12 patients diagnosed with SAS, treated with continuous positive airway pressure (CPAP), and 12 matched controls. Daytime somnolence, mental fatigue, and levels of activation during the tests, were also evaluated in both groups through the use of questionnaires.

Results: Although patients with SAHS showed higher daytime somnolence, they did not exhibit more risk driving behaviors than the control group. There were no differences in mental fatigue or levels of activation during the simulation.

Conclusion: Unlike the results found in classical studies, when the evaluation is carried out with more ecological tools and the duration of the tests is much shorter, the performance of patients with SAS treated with CPAP does not differ from that of the control group. These findings support the use of CPAP as well as the testing of drivers using virtual simulations in order to obtain a driver's license, especially in high risk populations.

目的:关于睡眠呼吸暂停低通气综合征(SAHS)患者的交通事故发生率较高,科学界存在很大的共识。然而,这种关系的某些方面仍然需要澄清。目前还不可能表明造成如此高的事故率的可能原因,可能存在不受控制的混杂因素,并且所使用的一些评估工具的生态效度较低。该研究的目的是在模拟交通的虚拟现实环境中分析SAS患者驾驶时的风险行为。材料与方法:采用Honda Riding Trainer模拟器对危险驾驶行为进行评价。参与者是12名诊断为SAS的患者,接受持续气道正压通气(CPAP)治疗,以及12名匹配的对照组。白天嗜睡、精神疲劳和测试期间的激活水平,也通过使用问卷对两组进行了评估。结果:尽管SAHS患者白天嗜睡程度较高,但其危险驾驶行为并未高于对照组。在模拟过程中,精神疲劳或激活水平没有差异。结论:与经典研究的结果不同,当评估采用更多的生态工具且测试时间短得多时,经CPAP治疗的SAS患者的表现与对照组没有差异。这些发现支持使用CPAP以及使用虚拟模拟测试驾驶员以获得驾驶执照,特别是在高风险人群中。
{"title":"Conductas de riesgo en pacientes con síndrome de apneas-hipopneas del sueño: estudio exploratorio en situaciones complejas y dinámicas de tráfico simulado","authors":"L.L. Di Stasi ,&nbsp;C. Díaz–Piedra ,&nbsp;A. Catena ,&nbsp;G. Buela–Casal","doi":"10.1016/S1576-9895(12)70148-0","DOIUrl":"10.1016/S1576-9895(12)70148-0","url":null,"abstract":"<div><p><em>Objective</em>: A large consensus exists within the scientific community with regard to the existence of a high incidence of traffic accidents in people with Sleep Apnea Hypopnea Syndrome (SAHS). However, some aspects of this relationship are still in need of clarification. It has not been possible to show the likely cause of this large rate of accidents, there are possible uncontrolled, confounding factors, and some of the evaluation instruments used have low ecological validity. The goal of the study was to analyze risk behavior during driving in patients with SAS, in a virtual reality setting with simulated traffic.</p><p><em>Material and methods</em>: Evaluation of risk driving behavior was carried out using the Honda Riding Trainer simulator. The participants were 12 patients diagnosed with SAS, treated with continuous positive airway pressure (CPAP), and 12 matched controls. Daytime somnolence, mental fatigue, and levels of activation during the tests, were also evaluated in both groups through the use of questionnaires.</p><p><em>Results</em>: Although patients with SAHS showed higher daytime somnolence, they did not exhibit more risk driving behaviors than the control group. There were no differences in mental fatigue or levels of activation during the simulation.</p><p><em>Conclusion</em>: Unlike the results found in classical studies, when the evaluation is carried out with more ecological tools and the duration of the tests is much shorter, the performance of patients with SAS treated with CPAP does not differ from that of the control group. These findings support the use of CPAP as well as the testing of drivers using virtual simulations in order to obtain a driver's license, especially in high risk populations.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 3","pages":"Pages 78-84"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70148-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
¿Influye la experiencia del operador en la rentabilidad de la broncoscopia en el diagnóstico de lesiones pulmonares focales malignas? 在诊断恶性局灶性肺病变时,操作人员的经验是否影响支气管镜检查的盈利能力?
Q4 Medicine Pub Date : 2012-04-01 DOI: 10.1016/S1576-9895(12)70139-X
R.M. Díaz Campos , R. García Luján , R. Alonso Moralejo , C. García Quero , E. de Miguel Poch

Introduction

The fiberoptic bronchoscopy (FB) is a useful technique in the diagnosis of focal pulmonary nodules and masses. The profitability of the FB and transbronchial biopsy (TB) is variable and depends on different factors such as the operator's experience. The aim of this study was to determine if the diagnostic profitability of these techniques, in the diagnosis of malignant focal pulmonary lesions (FPL), changed with the incorporation of a new medical staff compared with previous data of our center.

Material and methods

A FPL was defined as an intra - parenchymatous pulmonary lesion that is well circumscribed and completely surrounded by healthy lung.

We analyzed all the FBs between 02/2008 and 08/2009 in patients with a FPL with a definitive diagnosis of malignancy. 85 patients were included.

Results

The diagnostic profitability of the TB was 0.55; it was higher when the FPL was > 2 cm (≤ 2 cm vs > 2 cm; 0.38 vs 0.62; p = 0.02) but no difference was found by site (central vs. peripheral; 0.67 vs 0.54; p = 0.16). The previous profitability of TB was 0.76 without differences by size (≤ 2 cm vs > 2 cm; 0.72 vs 0,78; p = 0,48) or site (central vs peripheral; 0.83 vs 0.74; p = 0,39).

Conclusion

We conclude that the operator's experience influences in the diagnostic profitability of the TB, in the malignant FPL.

纤维支气管镜(FB)是诊断局灶性肺结节和肿块的有效技术。FB和经支气管活检(TB)的盈利能力是可变的,取决于不同的因素,如操作员的经验。本研究的目的是确定这些技术在诊断恶性局灶性肺病变(FPL)时的诊断价值是否随着新医务人员的加入而改变,并与本中心以往的数据进行比较。材料与方法FPL被定义为肺实质内病变,被健康肺完全包围。我们分析了2008年2月至2009年8月间确诊为恶性肿瘤的FPL患者的所有FBs。纳入85例患者。结果结核的诊断利润率为0.55;当FPL为>2cm(≤2cm vs >2厘米;0.38 vs 0.62;P = 0.02),但没有发现部位差异(中央vs外周;0.67 vs 0.54;p = 0.16)。TB的先前盈利能力为0.76,没有大小差异(≤2 cm vs >2厘米;0.72 vs 0.78;P = 0,48)或部位(中心vs外围;0.83 vs 0.74;p = 0,39)。结论手术人员的经验对结核病恶性FPL的诊断能力有一定影响。
{"title":"¿Influye la experiencia del operador en la rentabilidad de la broncoscopia en el diagnóstico de lesiones pulmonares focales malignas?","authors":"R.M. Díaz Campos ,&nbsp;R. García Luján ,&nbsp;R. Alonso Moralejo ,&nbsp;C. García Quero ,&nbsp;E. de Miguel Poch","doi":"10.1016/S1576-9895(12)70139-X","DOIUrl":"10.1016/S1576-9895(12)70139-X","url":null,"abstract":"<div><h3>Introduction</h3><p>The fiberoptic bronchoscopy (FB) is a useful technique in the diagnosis of focal pulmonary nodules and masses. The profitability of the FB and transbronchial biopsy (TB) is variable and depends on different factors such as the operator's experience. The aim of this study was to determine if the diagnostic profitability of these techniques, in the diagnosis of malignant focal pulmonary lesions (FPL), changed with the incorporation of a new medical staff compared with previous data of our center.</p></div><div><h3>Material and methods</h3><p>A FPL was defined as an intra - parenchymatous pulmonary lesion that is well circumscribed and completely surrounded by healthy lung.</p><p>We analyzed all the FBs between 02/2008 and 08/2009 in patients with a FPL with a definitive diagnosis of malignancy. 85 patients were included.</p></div><div><h3>Results</h3><p>The diagnostic profitability of the TB was 0.55; it was higher when the FPL was &gt; 2<!--> <!-->cm (≤ 2<!--> <!-->cm vs &gt; 2<!--> <!-->cm; 0.38 vs 0.62; p<!--> <!-->=<!--> <!-->0.02) but no difference was found by site (central vs. peripheral; 0.67 vs 0.54; p<!--> <!-->=<!--> <!-->0.16). The previous profitability of TB was 0.76 without differences by size (≤ 2<!--> <!-->cm vs &gt; 2<!--> <!-->cm; 0.72 vs 0,78; p<!--> <!-->=<!--> <!-->0,48) or site (central vs peripheral; 0.83 vs 0.74; p<!--> <!-->=<!--> <!-->0,39).</p></div><div><h3>Conclusion</h3><p>We conclude that the operator's experience influences in the diagnostic profitability of the TB, in the malignant FPL.</p></div>","PeriodicalId":37742,"journal":{"name":"Revista de Patologia Respiratoria","volume":"15 2","pages":"Pages 40-44"},"PeriodicalIF":0.0,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1576-9895(12)70139-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56525432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de Patologia Respiratoria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1